Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Apr;105(4):859-65.
doi: 10.1038/ajg.2010.55. Epub 2010 Feb 23.

The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial

Affiliations
Multicenter Study

The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial

William D Chey et al. Am J Gastroenterol. 2010 Apr.

Abstract

Objectives: There are limited data on the yield of colonoscopy in patients with irritable bowel syndrome (IBS). This study compared the prevalence of structural colonic lesions in patients with suspected non-constipation-predominant IBS and healthy volunteers. We also determined the yield of rectosigmoid biopsies in patients with suspected IBS.

Methods: This was a prospective, case-control study conducted at three US sites. Patients with suspected non-constipation-predominant IBS (Rome II) underwent colonoscopy with rectosigmoid biopsies. Healthy persons undergoing colonoscopy for colorectal cancer screening or polyp surveillance comprised the control group. Abnormalities identified at colonoscopy were compared between suspected IBS and control groups.

Results: In all, 466 suspected IBS patients and 451 controls were enrolled. Suspected IBS patients were significantly younger (P<0.0001) and more frequently female (P<0.0001) than controls. The most common lesions in suspected IBS patients were hemorrhoids (18.2%), polyps (14.6%), and diverticulosis (8.8%). Suspected IBS patients had a lower prevalence of adenomas (7.7% vs. 26.1%, P<0.0001) and diverticulosis (8.8% vs. 21.3%, P<0.0001) and higher prevalence of mucosal erythema or ulceration (4.9% vs. 1.8%, P<0.01) compared with controls. Logistic regression found the between-group differences in adenoma prevalence to be robust after correction for demographic factors. The overall prevalence of microscopic colitis in suspected IBS patients was 1.5% (7/466) and 2.3% (4/171) in those > or =45 years of age.

Conclusions: The prevalence of structural abnormalities of the colon is no higher in suspected non-constipation IBS patients than in healthy controls. Microscopic colitis can be identified in a small proportion of persons with IBS symptoms.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

Guarantor of the article : William D. Chey, MD, AGAF, FACG, FACP.

Potential competing interests : William D. Chey is a consultant for Albireo, Aryx, AstraZeneca, Ironwood, McNeil, Proctor & Gamble, Prometheus, Salix, Smart Pill Corporation, Takeda, and Xenoport and has been a speakers’ bureau member for Axcan, Prometheus, Salix, and Takeda. Borko Nojkov, Joel H. Rubenstein, and Richard R. Dobhan have no conflict of interest relevant to this study. Joel K. Greenson is a consultant for Millennium Pharmaceuticals, Glaxo-SmithKline, and Roche/Genentech. He is a shareholder in Amirsys Corporation. Brooks D. Cash is a consultant for Salix, Takeda, and Prometheus and has received research grants from Salix. He has been a speakers’ bureau member for Takeda, Salix, and Prometheus.

Comment in

Similar articles

Cited by

References

    1. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. - PubMed
    1. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005;22:935–942. - PubMed
    1. Hungin APS, Chang L, Locke GR, et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365–1375. - PubMed
    1. Saito YA, Talley NJ, J Melton L, et al. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003;15:687–694. - PubMed
    1. Spiegel BMR. Do physicians follow evidence-based guidelines in the diagnostic work-up of IBS? Nat Clin Pract Gastroenterol Hepatol. 2007;4:296–297. - PubMed

Publication types

MeSH terms